Navigation Links
Rare lung disease cells indicate higher death risk
Date:1/16/2008

r lavage. The technique involves passing a bronchoscope through the mouth of the patient and into the lungs. Saline is squirted into a small part of the affected lung and then recollected for examination.

The team evaluated the cell count of 156 people with IPF at the time the disease began to make its appearance.

With this information, we can now work to identify neutrophil cells in patients lungs and provide detailed information for more accurate diagnosis, says Kinder, who is also director of the newly established Interstitial Lung Disease Center at UC.

It is our hope that this accurate prognostic information will become even more useful as effective treatments become available.


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Smoking belies milder disease but worse prognosis for IPF patients
2. Sickle Cell Disease Pain Can Occur Daily and Is Much More Severe Than Previously Thought
3. MS Drug Tysabri Approved for Crohns Disease
4. Simple online methods increase physician disease reporting
5. Industrial Solvent May Increase Risk for Parkinsons Disease
6. Memantine and Alzheimers disease
7. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
8. Years-Long Search Unlocks Deadly Genetic Disease
9. International brain aging expert challenges the existence of Alzheimers as a disease
10. Transplant Drug Shrinks Tumors in Women With Rare Lung Disease
11. LifeMasters Receives Full URAC Disease Management Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...AST LANSING, Mich., May 12 /PRNewswire-USNewswire/...nostic radiologist, was installed as,president of ...MSMS) during,the 143rd annual meeting of the MSMS ...duate of the Wayne State University School of Medi...ment of Diagnostic Radiology at Henry,Ford Hospita...
(Date:5/12/2008)...ealthPartners hosts nine physicians from Chongqing...PRNewswire-USNewswire/ -- HealthPartners,Institute...medical,delegation of Chinese physicians ever to v... physicians will observe hospital- and clinic-base...al administration and,observe clinical research me...
(Date:5/12/2008)...OSTON, May 12 /PRNewswire-FirstCall/ -- PAREXEL In... today it will be presenting at the,Robert W. Bair...s. James,Winschel, Senior Vice President and Chief...ation on PAREXEL at 10:05 a.m. EDT on Thursday, Ma...will be available through the,"Investor Relations ...
(Date:5/12/2008)...alifornia Nurses Association charged with illegall...ring Iowa Caucuses for unsolicited mailers to,work...swire/ -- The California,Nurses Association (CNA) ...otional materials to 2,000 nurses represented by t...cal 199 according to a lawsuit filed on behalf,of ...
Breaking Medicine News(10 mins):Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:PAREXEL International to Present at Robert W. Baird's 2008 Growth Stock Conference 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 3
...d the particular bacteria causing some patients to...Forest University Baptist Medical Center has devel...et the germs. “We matched the best antibiotic comb...ics and the particular bugs that we have in our ho...
...ealth, the first case of bird flu has been reporte... Tuesday//. The fatal virus was confirmed on Sept... of the National Task Force on Bird Flu Sam Okware...ocal health and veterinary officials in various di...
...y researchers at Goteborg University, Sweden, freq...tain// chemicals in the cerebrospinal fluid. Thes...amage. This increase of chemicals in the brain may...k” syndrome and symptoms of lasting neurological d...
...which is often used as a treatment for gout, may a...atients with hepatitis virus-related end-stage liv...y. The study followed 186 patients with cirrhosis...6 received colchicine, while the others received n...
Other Medicine News:Health News:By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment 2Health News:Punch-Drunk Effect- Every blow matters 2
(Date:5/9/2008)...swire-USNewswire/ -- Osteoarthritis is a,painful a... almost 50,million people in the United States. It...oints. The novel investigational pain medication,t...ided significant relief,for patients with joint-di..., and with fewer gastrointestinal side effects tha...
(Date:5/9/2008)...re-USNewswire/ -- The risk of the two major,prosta...ia (BPH), can be,reduced by changes in lifestyle, ...ght and eating a healthy diet. Alan Kristal, Dr.P....m at Fred Hutchinson Cancer Research,Center in Sea...need not,feel helpless against prostate cancer or ...
(Date:5/9/2008)...e III Study Shows Positive Results with X-ray ... May 9 /- Roche today announced one-y...owing that ACTEMRA(TM),(tocilizumab) can significa...oints in patients with rheumatoid arthritis (RA), ...ment. The study also demonstrated that ACTEMRA,red...
(Date:5/8/2008).../ -- Globus Medical, Inc., the largest,privately h... recognized,leader in motion preservation technolo...n its SECURE(R)-C Cervical Artificial Disc IDE stu...e normal motion of the spine in,order to alleviate...sion in,the treatment of symptomatic cervical disc...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2AUDIO from Medialink and GlaxoSmithKline 3A Fiber Key in Managing Irritable Bowel Syndrome 28IBS 29 Symptoms 77 1ONCOSCIENCE AG THE EUROPEAN PARTNER OF YM BIOSCIENCES ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 73 1ONCOSCIENCE AG THE EUROPEAN PARTNER OF YM BIOSCIENCES ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 73 2ONCOSCIENCE AG THE EUROPEAN PARTNER OF YM BIOSCIENCES ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 73 3ONCOSCIENCE AG THE EUROPEAN PARTNER OF YM BIOSCIENCES ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB 73 4China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 1China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 2China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 3China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 4China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 5China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 6China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 7China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 8China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 9China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 69 10Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp 65 1
... in Patients with,Chronic Decompensated Heart Fail...y 56th Annual Scientific Session --, MOUNTAIN VIEW...re/ -- Scios Inc. announced today that an explorat...RECOR(R)) showed a,neutral effect on the primary e...italization at 12 weeks, and provides important,re...
...y Endpoint of,In-Segment Late Loss, Non-Inferiorit...lure and Superiority in Major Adverse Cardiac,Even...ARK, Ill., March 24, 2007 /PRNewswire-FirstCall/ -...S. pivotal clinical,trial at the of Cardiology,s 5...strated the following key results: , , -- The ...
Other Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 2Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 3Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 4Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 5
Safe-Wrap Combo Blood Collection Tubes are used for the collection of capillary blood samples for use with i-STAT blood gas, electrolyte, and chemistry cartridges requiring either 95 L or 65 L of sam
...r's FEMTO LDV, the first compact, mobile femtoseco... versatile, powerful platform for a wide spectrum ...em addresses the demand of refractive surgeons for...t with an efficient LASIK work-flow. The solution ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure.
Classic, stylish, and preppy, this collection features men's, women's and unisex styles.
Medicine Products: